EUVIMEDEUVIMED entdecken
Crossref

Design, Synthesis, and Cytotoxicity Evaluation of Styryl‐Spirooxindole Carboxamides as Potential Tubulin and VEGFR‐2 Dual Inhibitors

Sowmya Dastari, Vasavi Pasupuleti, Malyala Sai Madhurya, Anamika Sharma, Chandraiah Godugu iD, Nagula Shankaraiah iD

ChemMedChem · 15.12.2025 · 20 (24)

DOI: 10.1002/cmdc.202500634 ↗

Kurz gefasst

Fachartikel in der Zeitschrift ChemMedChem, online erschienen am 03.11.2025. Verfasst von Sowmya Dastari und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicinal Chemistry, National Institute of Pharmaceutical Education and Research (NIPER), Hyderabad, 500037, India. Hauptthemen laut MEDLINE: Vascular Endothelial Growth Factor Receptor-2, Tubulin, Drug Design, Antineoplastic Agents. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 45 Literaturangaben. Gefördert von: Department of Pharmaceuticals, Ministry of Chemicals and Fertilizers, India.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

In the pursuit of novel therapeutic agents for cancer treatment, a series of styryl‐spirooxindole‐based carboxamide derivatives are designed and synthesized, targeting dual inhibition of tubulin polymerization and VEGFR‐2 kinase. Among the synthesized compounds, 9j demonstrates remarkable potency against A549 (lung cancer) cell line with an IC 50 value of 0.89 ± 0.14 μM. The efficacy of 9j is significantly surpassed by that of the standard drugs colchicine (IC 50 = 1.66 ± 0.16 μM) and sunitinib (IC 50 = 2.98 ± 0.4 μM). Furthermore, compound 9j exhibits 66% growth inhibition in HUVEC cells with an IC 50 value of 1.2 ± 0.2 μM, as assessed by the MTT assay. Mechanistic studies confirm the apoptotic activity of compound 9j , as evidenced by its ability to induce mitochondrial dysfunction and promote apoptosis. Further, the apoptosis is quantified through Annexin V/PI dual staining assay. Additionally, enzymatic assays highlight the dual inhibitory activity of 9j against tubulin polymerization (IC 50 = 1.1 μM) and VEGFR‐2 kinase (IC 50 = 0.95 ± 0.5 μM). In continuation, the anti‐angiogenic effect of 9j is also evaluated by CAM assay. Moreover, molecular docking studies also reveal critical binding interactions within the active sites of both targets. Pharmacokinetic evaluations using QikProp and SwissADME tools further underscore the drug‐like properties of compound 9j , strengthening its potential as a lead molecule. This comprehensive study indicates that compound 9j is a promising lead in the realm of dual‐targeting anti‐cancer strategies, warranting further development and optimization.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Vascular Endothelial Growth Factor Receptor-2TubulinDrug DesignAntineoplastic AgentsOxindolesTubulin ModulatorsProtein Kinase InhibitorsIndolesSpiro CompoundsHumansStructure-Activity RelationshipDrug Screening Assays, AntitumorApoptosisCell ProliferationMolecular StructureDose-Response Relationship, DrugMolecular Docking SimulationHuman Umbilical Vein Endothelial CellsBenzopyransNitriles

Stichwörter der Autor:innen

VEGFR‐2anticancerapoptosisdual inhibitionlung cancerspirooxindoletubulin

Substanzen

Vascular Endothelial Growth Factor Receptor-2TubulinAntineoplastic AgentsOxindolesTubulin ModulatorsKDR protein, humanProtein Kinase InhibitorsIndoles2-oxindoleSpiro Compounds

Autor:innen und Institutionen

  • Department of Medicinal Chemistry, National Institute of Pharmaceutical Education and Research (NIPER), Hyderabad, 500037, India.
  • Department of Biological Sciences, National Institute of Pharmaceutical Education and Research (NIPER), Hyderabad, 500037, India.

ORCID-Profile: Chandraiah Godugu, Nagula Shankaraiah

Förderung

  • Department of Pharmaceuticals, Ministry of Chemicals and Fertilizers, India

Zitieren

APA

Dastari, S., Pasupuleti, V., Madhurya, M. S., Sharma, A., Godugu, C., & Shankaraiah, N. (2025). Design, Synthesis, and Cytotoxicity Evaluation of Styryl‐Spirooxindole Carboxamides as Potential Tubulin and VEGFR‐2 Dual Inhibitors. ChemMedChem, 20(24). https://doi.org/10.1002/cmdc.202500634

Vancouver

Dastari S, Pasupuleti V, Madhurya MS, Sharma A, Godugu C, Shankaraiah N. Design, Synthesis, and Cytotoxicity Evaluation of Styryl‐Spirooxindole Carboxamides as Potential Tubulin and VEGFR‐2 Dual Inhibitors. ChemMedChem. 2025;20(24). doi:10.1002/cmdc.202500634

BibTeX
@article{Dastari2025,
  author = {Dastari, Sowmya and Pasupuleti, Vasavi and Madhurya, Malyala Sai and Sharma, Anamika and Godugu, Chandraiah and Shankaraiah, Nagula},
  title = {Design, Synthesis, and Cytotoxicity Evaluation of Styryl‐Spirooxindole Carboxamides as Potential Tubulin and VEGFR‐2 Dual Inhibitors},
  journal = {ChemMedChem},
  year = {2025},
  volume = {20},
  number = {24},
  doi = {10.1002/cmdc.202500634}
}
Kostenlos starten →